Morgan Stanley analyst Craig Hettenbach downgraded HCA Healthcare (HCA) to Underweight from Equal Weight with an unchanged price target of $425. Following the stock’s significant outperformance that has HCA trading at a new peak valuation multiple, “there’s little room for any setbacks,” the analyst tells investors in a research note. The firm thinks upside is already priced in following strong outperformance in the stock.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- Hospital stocks lower after Republicans propose Medicare funding cut
- HCA Healthcare price target raised to $431 from $412 at Wells Fargo
- HCA Healthcare Issues $3.25 Billion in Senior Notes
- HCA Healthcare price target raised to $525 from $485 at Jefferies
- HCA Healthcare Announces Senior Notes Offering